Cargando…
Teriparatide Therapy as an Adjuvant for Tissue Engineering and Integration of Biomaterials
Critically sized large bone defects commonly result from trauma, radical tumor resections or infections. Currently, massive allografting remain as the clinical standard to treat these critical defects. Unfortunately, allograft healing is limited by the lack of osteogenesis and bio-integration of the...
Autores principales: | Dhillon, Robinder S., Schwarz, Edward M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156480/ https://www.ncbi.nlm.nih.gov/pubmed/21857768 http://dx.doi.org/10.3390/ma4061117 |
Ejemplares similares
-
Platelet-rich plasma therapy - future or trend?
por: Dhillon, Robinder S, et al.
Publicado: (2012) -
Adjuvant Teriparatide Therapy for Surgical Treatment of Femoral Fractures; Does It Work?
por: Kim, Jung Taek, et al.
Publicado: (2016) -
Integration of microbubbles with biomaterials in tissue engineering for pharmaceutical purposes
por: Esmaeili, Javad, et al.
Publicado: (2020) -
Biomaterials and tissue engineering
por: Shi, Donglu
Publicado: (2004) -
Theranostic biomaterials for tissue engineering
por: Kharbikar, Bhushan N., et al.
Publicado: (2021)